Home / Aprepitant / Italy
IT ATC A04AD12 · updated 2 Nov 2026
Aprepitant shortage in Italy
Is there an Aprepitant shortage in Italy?
Yes. As of 2 Nov 2026, 4 Aprepitant products are reported short in Italy, the first since 15 Jan 2024. The company estimate for the return is 31 Mar 2027. Main reason: manufacturing problem.
Also short in United States, Canada, Germany, France, Spain, Ireland, Austria, Czechia, Norway, Sweden, Australia. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | APREPITANT ACCORD discontinuation | ACCORD HEALTHCARE, S.L.U. | 15 Jan 2024 | not given | Manufacturing problem Problemi produttivi |
| IT | ATANTO discontinuation | GLENMARK PHARMA S.R.L. | 5 May 2026 | not given | Manufacturing problem Problemi produttivi: distribuzione contingentata |
| IT | FOSAPREPITANT ACCORD | ACCORD HEALTHCARE, S.L.U. | 19 Oct 2026 | not given | Increased demand Elevata richiesta |
| IT | IVEMEND anticipated | MERCK SHARP & DOHME B.V. | 7 Nov 2026 | 31 Mar 2027 | Manufacturing problem Problemi produttivi |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.